1Nisa AU, Ahmad Z. Dubin-Johnson syndrome[ J]. J Coll Physicians Surg Pak ,2008,18 ( 3 ) : 188 - 189.
2Lai Y, Xing L, Poda GI, et al. Structure-activity relationships for interaction with multidrug resistance protein 2 (ABCC2/MRP2) :the role of torsion angle for a series of biphenyl-substituted heterocycles[J]. Drug Metab Dispos,2007,35(6) :937 -945.
3Kast HR, Goodwin B, Tarr PT, et al. Regulation of muhidrug resistance-associated protein 2 ( ABCC2 ) by the nuclearreceptors pregnane X receptor ,farnesoid X-activated receptor, and constitutive androstane receptor[ J ]. J Biol Chem, 2002,277 (4) : 2908 - 2915.
4Payen L, Sparfel L, Courtois A, et al. The drug efflux pump MRP2: regulation of expression in physiopathological situations and by endogenous and exogenous compounds [ J]. Cell Biol Toxicol, 2002,18(4) : 221 -233.
5Jedlitschky G, Hoffmann U, Kroemer HK. Structure and function of the MRP2 (ABCC2) protein and its role in drug Disposition [ J ]. Expert Opin Drug Metab Toxicol, 2006,2 ( 3 ) :351 - 366.
6Mano Y, Usui T, Kamimura H. Effects of bosentan, an endothelin receptor antagonist, on bile salt export pump and multidrug resistance-associated protein 2[J]. Biopharm Drug Dispos, 2007, 28(1) :13 -18.
7Wakamatsu T, Nakahashi Y, Hachimine D, et al. The combination of glycyrrhizin and lamivudine can reverse the cisplatin resistance in hepatocellular carcinoma ceils through inhibition of multidrug resistance-associated proteins [ J ]. Int J Oncol, 2007, 31 (6) : 1465 - 1472.
8Ishikawa T, Ali-Osman F. Glutathione-associated cis-diamminedichloroplatinum ( Ⅱ ) metabolism and ATP-dependent efflux from leukemia cells. Molecular characterization of glutathione-platinum complex and its biological significance [ J ]. J Biol Chem, 1993,268 (27) :20116 - 20125.
9Negoro K, Yamano Y, Fushimi K, et al. Establishment and characterization of a cisplatin-resistant cell line, KB-R, derived from oral carcinoma cell line, KB [ J ]. Int J Oncol, 2007, 30 (6) :1325 - 1332.
10Demeule M, Brossard M, Beliveau R. Cisplatin induces renal expression of P-glycoprotein and canalicular multispecific organic anion transporter [ J ]. Am J Physiol, 1999,277 ( 6 ) : 832 - 840.
4Valera ET,Machado HR,Scrideli CA,et al.Drug resistance in central nervous system tumors:from the traditional cell-resistance model to the genetically driven approaches on therapy[J].Curr Pharm Biotechnol,2007,8 (2):105-113.
5Spiegl-Kreinecker S,Buchroithner J,Elbling L,et al.Expression and functional activity of the ABC-transporter proteins P-glycoprotein and mutidrug-resistance protein1in human brain cells and astrocytes[J].J Neurooncol,2002,57(1):27-36.
6Sadanand V,Kankesan J,Yusuf A,et al.Effect of PSC833,a potent inhibitor of P-glycoprotein,on the growth of astrocytomas cells in vitro[J].Cancer Lett,2003,198(1):21-27.
